A case of restless leg syndrome in a family with LRRK2 gene mutation

International Journal of Neuroscience

Volumn 123, Issue 4, 2013, Pages 283-285

  De Rosa, Anna ^a   Guacci, Anna ^a   Peluso, Silvio ^a   Del Gaudio, Luigi ^a   Massarelli, Marco ^a   Barbato, Stefano ^a   Criscuolo, Chiara ^a   De Michele, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

LRRK2 gene; Parkinson disease; Restless leg syndrome

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; ROPINIROLE;

AGED; ARTICLE; BEDTIME DOSAGE; BRADYKINESIA; CASE REPORT; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MUSCLE RIGIDITY; MUTATIONAL ANALYSIS; PARKINSON DISEASE; RESTLESS LEGS SYNDROME; SEQUENCE ANALYSIS;

AGED; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE; HUMANS; MALE; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; RESTLESS LEGS SYNDROME;

EID: 84875202289     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.756485     Document Type: Article

References (18)

1. Kumari U, Tan EK. LRRK2 in Parkinson's disease: genetic and clinical studies from patients. FEBS J 2009;276: 6455-63.
2. Paisán-Ruiz C. LRRK2 gene variation and its contribution to Parkinson disease. Hum Mutat 2009;30:1153-60.
3. Haugarvoll K, Wszolek ZK. Clinical features of LRRK2 parkinsonism. Parkinsonism Relat Disord 2009;15 Suppl 3: S205-8.
4. Peeraully T, Tan EK. Genetic variants in sporadic Parkinson's disease: East vsWest. Parkinsonism Relat Disord 2012;18 Suppl 1:S63-5.
5. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med 2003;4:101-19.
6. Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath 2012;16:987-1007.
7. Verbaan D, van Rooden SM, van Hilten JJ, et al. Prevalence and clinical profile of restless legs syndrome in Parkinson's disease. Mov Disord 2010;25:2142-7.
8. M̈ oller JC, Unger M, Stiasny-Kolster K, Oertel WH. Restless legs syndrome (RLS) and Parkinson's disease (PD)-related disorders or different entities? J Neurol Sci 2010;289:135-7.
9. Pittock SJ, Parrett T, Adler CH, et al. Neuropathology of primary restless leg syndrome: absence of specific tau-and alphasynuclein pathology. Mov Disord 2004;19:695-9.
10. Tan EK, Yew K, Chua E, et al. PINK1 mutations in sporadic early onset Parkinson's disease. Mov Disord 2006;21:789-93.
11. Adel S, Djarmati A, Kabakci K, et al. Co-occurrence of restless legs syndrome and Parkin mutations in two families. Mov Disord 2006;21:258-63.
12. Puschmann A, Pfeiffer RF, Stoessl AJ, et al. A family with parkinsonism, essential tremor, restless legs syndrome, and depression. Neurology 2011;76:1623-30.
13. Michaud M, Soucy JP, Chabli A, et al. SPECT imaging of striatal pre-and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 2002;249:164-70.
14. Wider C, Dakson DH, Wszolek ZK. Leuchine-rich repeat kinase2 gene associated disease. Redefining genotype-phenotype correlation. Neurodegen Dis 2010;7:175-9.
15. Dachsel JC. Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions. Acta Neuropathol 2007;1113:601-6.
16. Santos-Rebouças CB, Abdalla CB, Martins PA, et al. LRRK2 p.G2019S mutation is not common among Alzheimer's disease patients in Brazil. Dis Markers 2009;27:13-6.
17. Chen-Plotkin AS, Yuan W, Anderson C, et al. Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology 2008;70:521-7.
18. Covy JP, Yuan W, Waxman EA, et al. Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations. Mov Disord 2009;24:32-9.